India’s primary market pipeline continues to remain active, with the upcoming GSP Crop Science IPO preparing to open for subscription next week. The agrochemical manufacturer plans to raise ₹400 crore through a book-built issue that combines a fresh issue of equity shares with an offer for sale by existing shareholders.
The IPO will open on March 16, 2026, and close on March 18, 2026, offering investors exposure to a company operating in India’s expanding crop protection industry. Following the completion of the bidding process, the company is expected to finalise share allotments on March 20, while the shares are tentatively scheduled to list on the Bombay Stock Exchange and the National Stock Exchange of India on March 24, 2026.
The public offering comes at a time when India’s agrochemical industry is gaining prominence globally due to its manufacturing capabilities, rising exports, and growing demand for crop protection products. For investors tracking the primary market, the issue represents another opportunity to participate in a sector linked closely to agricultural productivity and global food security.
Also Check :
Issue Structure, Price Band and Investment Requirements
The public issue consists of 1.25 crore equity shares, translating to an issue size of ₹400 crore at the upper end of the price band.
The structure of the IPO includes:
• Fresh Issue: 0.75 crore shares aggregating to ₹240 crore
• Offer for Sale: 0.50 crore shares aggregating to ₹160 crore
The company has set the price band at ₹304 to ₹320 per share, with a lot size of 46 shares for retail investors.
At the upper price band, the minimum investment required for retail investors stands at ₹14,720.
Key IPO Details
| Particular | Details |
|---|---|
| IPO Dates | March 16 – March 18, 2026 |
| Price Band | ₹304 – ₹320 per share |
| Face Value | ₹10 per share |
| Issue Size | ₹400 crore |
| Fresh Issue | ₹240 crore |
| Offer for Sale | ₹160 crore |
| Lot Size | 46 shares |
| Listing | BSE & NSE |
The IPO is being managed by Equirus Capital, which is acting as the book-running lead manager, while MUFG Intime India will handle the share allotment and investor services for the issue.
GSP Crop Science IPO Timeline: Key Dates Investors Should Track
Like most public offerings in India, the IPO will follow a defined process that includes the subscription window, allotment, refunds, and listing.
Important Dates
| Event | Date |
|---|---|
| IPO Opens | March 16, 2026 |
| IPO Closes | March 18, 2026 |
| Allotment Finalisation | March 20, 2026 |
| Refund Initiation | March 23, 2026 |
| Shares Credited to Demat | March 23, 2026 |
| Listing Date | March 24, 2026 |
Once the allotment is finalised, investors can check their allotment status through the registrar’s website.
Here’s What Happened Today and Why IPO Investors Are Watching This Issue
Several developments are drawing investor attention to the upcoming public issue and the agrochemical sector more broadly.
Key factors influencing investor interest include:
• Rising global demand for crop protection products
• India’s growing role as a manufacturing hub for agrochemicals
• Strong export opportunities for domestic agrochemical companies
• Continued retail participation in IPOs supported by domestic liquidity
• Diversification opportunities within the specialty chemical ecosystem
For market participants, these trends suggest that agrochemical companies with established manufacturing capabilities and export presence could attract steady investor attention in the primary market.
About GSP Crop Science: A Crop Protection Company With Global Reach
Founded in 1985, GSP Crop Science operates in the agrochemical industry and focuses on producing crop protection solutions designed to improve agricultural productivity.
The company manufactures a range of products including:
• Insecticides
• Herbicides
• Fungicides
• Plant growth regulators
These products help farmers protect crops against pests, weeds and diseases, contributing to improved crop yields and agricultural efficiency.
Over the years, the company has developed integrated capabilities in research, manufacturing, formulation and distribution of agrochemical products.
Domestically, the company has served customers across 20 Indian states during the six months ended September 30, 2025 and the financial years between 2023 and 2025.
Internationally, the company exports products to 37 countries, including:
• United States
• Brazil
• Uruguay
• Vietnam
• Singapore
• UAE
• Australia
This diversified export presence allows the company to participate in multiple agricultural markets across Latin America, North America and Asia-Pacific regions.
Business Segments: Formulations and Technicals
The company’s operations are structured around two key segments that together form the core of its agrochemical business.
Formulations
The formulations segment consists of finished agrochemical products that combine active ingredients with additives to create ready-to-use crop protection solutions.
As of September 30, 2025, the company had 395 registrations for formulation products, available in both liquid and solid forms.
These products are marketed under the company’s own brands or through licensed brands across different geographies.
Technicals
The technicals segment involves manufacturing concentrated active ingredients that serve as the base components used in agrochemical production.
As of September 30, 2025, the company had 129 registrations for technical products, highlighting its expertise in producing key agrochemical compounds.
This vertical integration allows the company to maintain better control over production quality and supply chains.
Research, Patents and Product Innovation
Research and development form an important part of the company’s strategy to remain competitive in the agrochemical sector.
As of September 30, 2025, the company had obtained 524 product registrations covering both formulations and technical products.
Its intellectual property portfolio includes:
• 102 granted patents
• 108 patent applications under review as of March 10, 2026
To support product innovation, the company operates dedicated R&D centres in Kathwada and Odhav, where scientists focus on product testing, formulation development and commercialisation.
The company employed 1,221 permanent employees as of September 30, 2025, reflecting the scale of its manufacturing and research operations.
Investment Requirements for Retail and Non-Institutional Investors
Investors must apply for shares in multiples of the lot size specified in the IPO.
Investment Details
| Investor Category | Lots | Shares | Investment (₹320 Upper Price) |
|---|---|---|---|
| Retail Investors | 1 lot | 46 shares | ₹14,720 |
| Small NII (sNII) | 14 lots | 644 shares | ₹2,06,080 |
| Big NII (bNII) | 68 lots | 3,128 shares | ₹10,00,960 |
Retail investors can apply for a minimum of one lot, while non-institutional investors must apply for higher quantities depending on their investment category.
GSP Crop Science IPO GMP Shows Neutral Sentiment Ahead of Listing
The Grey Market Premium (GMP) often provides an early indication of investor sentiment toward an IPO before its listing.
As of March 14, 2026, the GMP for the GSP Crop Science IPO stands at ₹0, indicating neutral expectations in the unofficial market.
GMP Trend
| Date | IPO Price | GMP | Estimated Listing Price | Estimated Profit |
|---|---|---|---|---|
| Mar 14, 2026 | ₹320 | ₹0 | ₹320 | ₹0 |
| Mar 13, 2026 | ₹320 | ₹0 | ₹320 | ₹0 |
| Mar 12, 2026 | ₹320 | ₹0 | ₹320 | ₹0 |
However, market experts caution that GMP is unofficial, highly volatile and unregulated, meaning investors should not rely solely on grey market signals when evaluating an IPO.
How Investors Can Check GSP Crop Science IPO Allotment Status
The allotment of shares is expected to be finalised on March 20, 2026.
Investors can check their allotment status through the registrar’s website by following these steps:
• Visit the registrar’s IPO allotment webpage
• Select GSP Crop Science from the IPO list
• Choose PAN, application number or DP Client ID as identification
• Enter the required details
• Click “Search” to view allotment results
The page will display the number of shares applied for and the number of shares allotted.
Understanding the Basis of Allotment in the IPO
After the subscription process closes, the registrar prepares the Basis of Allotment (BOA) document, which explains how shares are distributed among different categories of investors.
The BOA report includes details such as:
• Total applications received in each investor category
• Shares reserved for QIBs, NIIs and retail investors
• Allocation ratio used for allotment
For example, if the allocation ratio is 1:10, it means one out of every ten applicants receives one lot of shares.
This document helps investors understand the demand for the IPO and the likelihood of receiving an allotment.
